6% of revenue invested in R&D. 40+ scientists. 12 patents. From molecule to market — we develop formulations that make a difference.
Oral solids (IR, SR, MR, EC), liquids, semi-solids, injectables, dry syrups. Taste-masking, stability enhancement, bioavailability improvement.
HPLC, GC, UV-Vis, FTIR method development and validation per ICH Q2(R1). Forced degradation and impurity profiling.
ICH Q1A/Q1B compliant. Accelerated (40°C/75% RH), intermediate, and long-term conditions. Photostability per ICH Q1B.
Study design, CRO coordination, and regulatory filing support for BE studies. 50+ successful BE studies completed.
CTD/eCTD dossier preparation for India (CDSCO), US (ANDA), EU (ASMF/CEP), Africa (WHO PQ), and other regulated markets.
12 patents filed. FTO analysis, patent landscape mapping, and non-infringing formulation strategies.